PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies via a Polymer Drug Conjugate technology yielding to an optimal therapeutic index based on the innovative Sagitta™ technology.
Some insights
Sagitta™ technology addresses the challenge of obtaining superior therapeutic index with a biodegradable polymer conjugation technology. Sagitta™ platforms reinforce ideal performances for therapeutic index,and improved PK parameters that are experimentally proven to be translatable across species.